Lipid-Lowering Drugs and Cognitive Function Decline
The cardiovascular benefits of lipid-lowering therapy have been confirmed by a large number of experiments,but whether the decrease of low-density lipoprotein cholesterol will lead to the decline of cognitive function is also gradually causing concern.As new cholesterol-lowering drugs continue to hit the market,the limit that low-density lipoprotein cholesterol can reach is getting lower and lower.This article reviews the current research status on the effects of lipid-lowering drugs such as statins,cholesterol absorption inhibitors,and proprotein convertase subtilisin/kexin 9 inhibitors on cognitive function.
Lipid-lowering drugsLow-density lipoprotein cholesterolCognitive function
NETL
NSTL
万方数据
